ARCHIVES

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

This article is from The Cancer Letter archive.

Vol. 28 No. 31 | August 2, 2002

Download PDF Visit The Full Archive

Related Articles

April issue of Business & Regulatory Report included (8 additional pages).

April 30, 2004

Beth Israel Suspends Enrollment In Trials Following An Audit

October 22, 2010

Danish Researchers Post Long-Awaited Aranesp Results–Ever So Discreetly.

February 16, 2007

Organ Systems Coordinating Center Deadline Extended

August 5, 1983

NCAB Review Of Cancer Control Program Finds It Has Made Substantial Progress But Has Problems

October 13, 1978

Pain Relievers Protect Against Breast Cancer

April 25, 2003